MAPT and Alzheimer disease: Preclinical and clinical studies have demonstrated that bioactive compounds such as polyphenols, alkaloids, terpenoids, saponins, and flavonoids exert beneficial effects on AD-related pathways by reducing oxidative stress, suppressing neuroinflammation, preventing Aβ aggregation, and modulating tau hyperphosphorylation (Liu et al., 2024).